{"title":"埃图格列净(Steglatro):抑制SGLT2的新选择。","authors":"Nikolas Kovacich, Benjamin Chavez","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Steglatro (ertugliflozin) for glycemic control in adults with type-2 diabetes mellitus.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"736-742"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281144/pdf/ptj4312736.pdf","citationCount":"0","resultStr":"{\"title\":\"Ertugliflozin (Steglatro): A New Option for SGLT2 Inhibition.\",\"authors\":\"Nikolas Kovacich, Benjamin Chavez\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Steglatro (ertugliflozin) for glycemic control in adults with type-2 diabetes mellitus.</p>\",\"PeriodicalId\":38773,\"journal\":{\"name\":\"P and T\",\"volume\":\"43 12\",\"pages\":\"736-742\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281144/pdf/ptj4312736.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"P and T\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"P and T","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
